Jason Bill, MD
Gastroenterology · Saint Louis, MONPI 1285920017
Payments from drug & device makers
What this record shows
This record is dominated by grants: $12,500 of the $13,423 with a category attached, or 93.1%. Boston Scientific accounts for 94.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $12,620 and has fallen 99.8% since, to $28 in 2024.
Across 11 payments — averaging $1220.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$13K
- Apollo Endosurgery US Inc$596
- Conmed Corporation$149
- BD$28
What the payments were for
- Grants$12,50093%
- Travel & lodging$2852%
- Food & beverage$6375%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $12,651 |
| Apollo Endosurgery US Inc | 6 | $596 |
| Conmed Corporation | 1 | $149 |
| BD | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,423 in reported general payments places this provider in the 80th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 40 | $79,153 |
| LinzessLinaclotide | 29 | $26,256 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 41 | $2,784 |
| Omeprazole | 184 | $2,279 |
| CholestyramineCholestyramine (With Sugar) | 14 | $2,224 |
| Sucralfate | 23 | $2,125 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 128 | $1,790 |
| Pantoprazole Sodium | 86 | $813 |
| Budesonide DrBudesonide | 13 | $585 |
| Misoprostol | 11 | $565 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 34 | $563 |
| Dicyclomine Hcl | 28 | $438 |
| Ondansetron OdtOndansetron | 31 | $333 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 21 | $332 |
| Torsemide | 15 | $203 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Saint Louis
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$730K
- David AlpersSaint Louis$616K
- Parakkal DeepakSaint Louis$205K
- Mauricio Lisker MelmanSaint Louis$179K
- Matthew CiorbaSaint Louis$156K
- Bruce BaconSaint Louis$138K
- Jeffrey CrippinSaint Louis$120K
- Vladimir KushnirSaint Louis$118K
- Kayci Huff-HardySaint Louis$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.